MTOR and gastric cancer: Especially in GC, Liu et al. reported that miR-101 could inhibit angiogenesis by down-regulating VEGF-C expression [60], and Riquelme et al. reported that miR-101 suppressed cell proliferation, migration, and invasion in gastric cancer cells through regulation of the PI3K/AKT/mTOR pathway [58].